A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate Cancer

Clinical trial NCT06990880 · RECRUITING

Trial details

NCT number: NCT06990880
Sponsor: GlaxoSmithKline
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neoplasms, Prostate

Start date: 2025-06-12
Primary completion: 2027-10-26
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.